Information
-
Trademark
-
98297806
-
International Classifications
-
Filing Date
December 04, 2023
a year ago
-
Transaction Date
December 17, 2024
5 days ago
-
Status Date
December 04, 2024
18 days ago
-
Published for Opposition Date
November 05, 2024
a month ago
-
Location Date
October 02, 2024
2 months ago
-
Status Code
774
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
SAUNDERS, ANDREA
-
Attorney Docket Number
V03392000500
Attorney Name
CHRISTINA M. LICURSI
Law Office Assigned Location Code
M80
-
Owners
Mark Drawing Code
4
Mark Identification
SAIL
Case File Statements
- GS0051: Pharmaceutical preparations for use in gene therapy; biological and pharmaceutical preparations, both comprised of therapeutic nucleic acids, namely RNA, for the treatment and prevention of genetic diseases and disorders, genomic diseases and disorders, cancer, infectious diseases, and immune system related diseases and disorders; Therapeutic preparations to modulate metabolism; pharmaceutical preparations and agents to modulate metabolism; pharmaceutical agents that modulate metabolism for scientific and research use; therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; therapeutic pharmaceuticals for modulating metabolism
- GS0421: Testing, inspection, research, and development of pharmaceutical preparations for gene therapy; research and development in the field of computational biology, biotechnology and pharmaceuticals
Case File Event Statements
-
12/4/2023 - a year ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
2/28/2024 - 9 months ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
7/2/2024 - 5 months ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
7/2/2024 - 5 months ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
7/2/2024 - 5 months ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
9/25/2024 - 2 months ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
9/25/2024 - 2 months ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
9/25/2024 - 2 months ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
9/26/2024 - 2 months ago
10 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
10/16/2024 - 2 months ago
11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
11/5/2024 - a month ago
12 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
11/5/2024 - a month ago
13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
7/2/2024 - 5 months ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
12/4/2024 - 18 days ago
14 - OPPOSITION PAPERS RECEIVED AT TTAB
Type: OPPF
-
12/4/2024 - 18 days ago
15 - OPPOSITION INSTITUTED NO. 999999
Type: OP.I